Johnston SS - Search Results

1

Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic.

Johnston SS, McMorrow D, Farr AM, Juneau P, Ogale S. Johnston SS, et al. Rheumatol Ther. 2015 Jun;2(1):59-71. doi: 10.1007/s40744-014-0006-3. Epub 2014 Dec 23. Rheumatol Ther. 2015. PMID: 27747492 Free PMC article.

2

Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic.

Johnston SS, McMorrow D, Farr AM, Juneau P, Ogale S. Johnston SS, et al. Drugs Real World Outcomes. 2015 Mar;2(1):99-109. doi: 10.1007/s40801-015-0018-5. Drugs Real World Outcomes. 2015. PMID: 27747619 Free PMC article.

3

Comparison between guideline-preferred and nonpreferred first-line HIV antiretroviral therapy.

Johnston SS, Juday T, Farr AM, Chu BC, Hebden T. Johnston SS, et al. Am J Manag Care. 2014 Jun;20(6):448-55. Am J Manag Care. 2014. PMID: 25180433 Free article.

4

No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting.

Farr AM, Johnston SS, Ritchings C, Brouillette M, Rosenblatt L. Farr AM, et al. Among authors: johnston ss. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19538. doi: 10.7448/IAS.17.4.19538. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394047 Free PMC article.

5

Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.

Farr AM, Sheehan JJ, Curkendall SM, Smith DM, Johnston SS, Kalsekar I. Farr AM, et al. Among authors: johnston ss. Adv Ther. 2014 Dec;31(12):1287-305. doi: 10.1007/s12325-014-0171-3. Epub 2014 Dec 12. Adv Ther. 2014. PMID: 25504156 Free PMC article.

6

Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting.

Farr AM, Johnston SS, Ritchings C, Brouillette M, Rosenblatt L. Farr AM, et al. Among authors: johnston ss. J Med Econ. 2016;19(4):386-96. doi: 10.3111/13696998.2015.1128942. Epub 2015 Dec 29. J Med Econ. 2016. PMID: 26640980 Free article.

7

Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors.

Farr AM, Sheehan JJ, Brouillette M, Smith DM, Johnston SS, Kalsekar I. Farr AM, et al. Among authors: johnston ss. Adv Ther. 2016 Jan;33(1):68-81. doi: 10.1007/s12325-015-0277-2. Epub 2016 Jan 2. Adv Ther. 2016. PMID: 26724938 Free PMC article.

8

Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia.

Johnston SS, Udall M, Alvir J, McMorrow D, Fowler R, Mullins D. Johnston SS, et al. Pain Med. 2014 Apr;15(4):562-76. doi: 10.1111/pme.12328. Epub 2014 Jan 16. Pain Med. 2014. PMID: 24433487

9

Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens.

Rosenblatt L, Farr AM, Johnston SS, Nkhoma ET. Rosenblatt L, et al. Among authors: johnston ss. Open Forum Infect Dis. 2016 Mar 30;3(2):ofw061. doi: 10.1093/ofid/ofw061. eCollection 2016 Mar. Open Forum Infect Dis. 2016. PMID: 27186585 Free PMC article.

10

Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study.

Rosenblatt L, Farr AM, Nkhoma ET, Nelson JK, Ritchings C, Johnston SS. Rosenblatt L, et al. Among authors: johnston ss. BMC Infect Dis. 2016 Sep 19;16:492. doi: 10.1186/s12879-016-1827-1. BMC Infect Dis. 2016. PMID: 27643691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters